Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01455623 · ClinicalTrials.gov registry record
Development and Validation of a Disability Severity Index for CMT
A clinical trial, sponsored by University of Iowa.
- Completed
- Registry status
- 291
- Enrollment target
NCT01455623 is a clinical trial that has completed, run by University of Iowa. The registered enrollment target is 291 participants.
The verdict
NCT01455623 has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- 291 participants
- Enrollment target
Study Summary
It is necessary for outcome measures to accurately reflect the state of health of a person in order for clinical trials to show benefit. The most commonly used outcome measure for Charcot Marie Tooth Disease (CMT) is the CMT Neuropathy Score, which uses cutoffs of points designated as mild (0-10 points), moderate (11-20) or severe (21-36). These terms are arbitrary. This study is looking to base mild, moderate, and severe on what both people affected with CMT and those who provide for people with CMT consider appropriate.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 291 participants |
| Start Date | 2011-06 |
| Est. Completion | 2014-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01455623
The ClinicalTrials.gov registry entry for NCT01455623 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 291 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01455623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01455623 about?
NCT01455623 is a clinical study titled "Development and Validation of a Disability Severity Index for CMT". It is necessary for outcome measures to accurately reflect the state of health of a person in order for clinical trials to show benefit. The most commonly used outcome measure for Charcot Marie Tooth Disease (CMT) is the CMT Neuropathy Score, which uses cutoffs of points designated as mild (0-10 poi...
What is the current status of trial NCT01455623?
This trial is currently completed. The enrollment target is 291 participants. The study started on 2011-06. Estimated completion is 2014-03.
Who is sponsoring clinical trial NCT01455623?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.